GL1X · GenesisL1 explorer

Research workbench

Crystal structure of BCL-xl in complex with the BAXBH3 domain

Analyse Crystal structure of BCL-xl in complex with the BAXBH3 domain in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3PL7
Type
protein
Length
308 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
BCL-2-like protein 1; Apoptosis regulator bax
UniProt
Q07817, Q07812
Pockets
5 · best druggability 0.49

Structure

x-ray diffraction · 3 distinct chains · 80% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABCL-2-like protein 1protein14177% helix, 0% strandQ07817
CApoptosis regulator baxprotein2692% helix, 0% strandQ07812
BBCL-2-like protein 1protein14179% helix, 0% strandQ07817

Pockets

5 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11540.490.7831empty
2910.420.7915empty
3880.410.7819empty
4860.360.7615empty
5640.330.7718empty

Interfaces

3 interfaces between chains.

  • A–C · 1025 Ų buried · 7 hydrogen bonds · protein-protein
  • C–B · 861 Ų buried · 8 hydrogen bonds · protein-protein
  • A–B · 272 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 3PL7 · Crystal structure of Bcl-xL in complex with the BaxBH3 domain · the same entry in another collection · chain A against A, TM-score 1.00
  • Q07817 · AlphaFold monomer V2.0 prediction for BCL-2-like protein 1 (Q07817) · a predicted model of the same protein · chain A against A, TM-score 0.98
  • Q07812 · AlphaFold monomer V2.0 prediction for apoptosis regulator bax (Q07812) · a predicted model of the same protein · chain C against A, TM-score 0.81

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.